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Abstract
Background: Glycosylation on the globular head of the hemagglutinin (HA) protein of influenza
virus acts as an important target for recognition and destruction of virus by innate immune proteins
of the collectin family. This, in turn, modulates the virulence of different viruses for mice. The role
of particular oligosaccharide attachments on the HA in determining sensitivity to collectins has yet
to be fully elucidated.
Methods: When comparing the virulence of H3N2 subtype viruses for mice we found that viruses
isolated after 1980 were highly glycosylated and induced mild disease in mice. During these studies,
we were surprised to find a small plaque variant of strain A/Beijing/353/89 (Beij/89) emerged
following infection of mice and grew to high titres in mouse lung. In the current study we have
characterized the properties of this small plaque mutant both in vitro and in vivo.
Results: Small plaque mutants were recovered following plaquing of lung homogenates from mice
infected with influenza virus seed Beij/89. Compared to wild-type virus, small plaque mutants
showed increased virulence in mice yet did not differ in their ability to infect or replicate in airway
epithelial cells in vitro. Instead, small plaque variants were markedly resistant to neutralization by
murine collectins, a property that correlated with the acquisition of an amino acid substitution at
residue 246 on the viral HA. We present evidence that this substitution was associated with the
loss of an oligosaccharide glycan from the globular head of HA.
Conclusion: A point mutation in the gene encoding the HA of Beij/89 was shown to ablate a glycan
attachment site. This was associated with resistance to collectins and increased virulence in mice.
Background
Mammalian serum and respiratory fluids contain a com-
plex mixture of proteins, some of which can inhibit
hemagglutination activity or neutralize the infectivity of
influenza viruses. Three classes of such inhibitors have
been reported. The α and γ inhibitors are sialylated glyco-
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receptor-binding site of influenza virus hemagglutinin
(HA) to block access to cellular receptors. The β inhibitors
are not receptor analogues, do not contain sialic acid and
act via a mechanism distinct to that of α and γ inhibitors.
Studies by Anders et al. demonstrated that the β inhibitors
in bovine and mouse serum were mannose-binding
lectins of the collectin family [1]. Collectins are large mul-
timeric proteins that bind to glycoconjugates rich in D-
mannose and N-acetylglucosamine in a Ca2+-dependent
manner and play an important role in innate host defence
against a range of microbial pathogens (reviewed by
[2,3]). Members of the collectin family include the serum
mannose-binding lectin (MBL), bovine serum proteins
conglutinin and collectin-43 (CL-43) and lung surfactant
proteins A (SP-A) and D (SP-D). For influenza viruses of
the H3 subtype, the oligosaccharide side-chain at the tip
of the HA spike was shown to be critical in determining
the sensitivity of the virus to the antiviral activities of col-
lectins in mouse and bovine serum [1]. Mutant viruses
selected in the presence of bovine serum (a rich source of
conglutinin) were shown to have lost this glycosylation
site and were resistant to hemagglutination inhibition by
β inhibitors [1].
Since their identification as β inhibitors, the role of col-
lectins in innate host defence against influenza viruses has
become an area of intense interest. MBL, conglutinin, CL-
43 and SP-D all act as classic β inhibitors, binding in a
Ca2+-dependent manner to oligosaccharides expressed on
the viral HA and NA glycoproteins. This mediates hemag-
glutination inhibition, neutralization, virus aggregation
and opsonization of virus to promote neutrophil respon-
siveness to the virus (reviewed by [2,4,5]). In contrast, the
collectin SP-A is a sialylated glycoprotein and therefore
acts as a γ inhibitor to mediate a similar range of antiviral
activities against influenza viruses [6,7]. Of particular
interest, both SP-A and SP-D are present in respiratory
secretions, although current evidence suggests that the
high avidity interaction between SP-D and carbohydrates
on the viral HA is a major factor contributing to the neu-
tralizing capacity of bronchoalvolar lavage fluids [8-10].
Since their appearance in the human population in 1968,
H3N2 subtype viruses have shown a progressive increase
in N-linked glycosylation in and around the globular
head of the HA molecule, while glycosylation sites located
in the stem region of HA tend to be highly conserved
[11,12]. Using a mouse model of influenza infection, we
have demonstrated that for viruses of the H3 subtype
(1968-1992), the level of glycosylation on the globular
head of HA of a particular virus strain inversely correlates
with its ability to replicate in vivo [8]. Virus strains bearing
high levels of glycosylation (1977-1992) were more sensi-
tive to neutralization by murine collectins, and this in
turn correlated with a poor ability to replicate in mouse
lung. In initial studies we were surprised to find that one
virus strain, A/Beijing/353/89 (Beij/89), did not fit this
trend and grew well in mouse lung despite the presence of
4 potential sites of N-linked glycosylation on the globular
head of HA. Studies were therefore undertaken to deter-
mine the mechanisms underlying the enhanced virulence
of this particular mutant for mice.
Methods
Viruses
A seed stock of wild-type (non-reassortant) A/Beijing/
353/89 (Beij/89) from the WHO Collaborating Centre for
Reference and Research on Influenza, Melbourne, Aus-
tralia and was propagated once at a 10-4 dilution in the
allantoic cavity of 10-day embryonated eggs to generate
an uncloned stock of Beij/89. When this stock was
plaqued on MDCK cell monolayers in the presence of
trypsin [8], two morphologically distinct plaque types
were observed; a predominant round plaque type approx-
imately 1 mm in diameter (large plaque phenotype), and
a minor subpopulation (<5%) of small, star-shaped
plaques (small plaque phenotype).
Plaque purification (PP) of virus was performed on
MDCK cells and was monitored by the distinctive plaque
morphology of the large and small plaque viruses. Well-
separated plaques were picked, resuspended in PBS and
inoculated into 10-day embryonated hens' eggs. Allantoic
fluid was harvested and the PP procedure repeated. Stocks
of allantoic fluid generated from the second PP were
plaqued to ensure appropriate morphology and frozen at
-70°C. Purified virus stocks were prepared using discon-
tinuous sucrose gradients as described [1].
Infection and treatment of mice
C57BL/6 mice were bred and maintained in the animal
facility of this department. Adult mice (6-8 weeks) were
used in all experiments. All research complied with the
University of Melbourne's Animal Experimentation Ethics
guidelines and policies. Mice were anaesthetized and
infected intranasally (i.n.) with 105 PFU of influenza virus
(unless otherwise stated) in 50 μl of PBS. Each day, mice
were weighed individually and monitored for signs of ill-
ness. To determine viral titres, mice were euthanized and
lungs and nasal tissues were removed and homogenates
were clarified by centrifugation. The samples were assayed
for infectious virus by plaque assay on MDCK monolayers
[8].
Differential leukocyte counts in bronchoalveolar lavage 
(BAL) fluids
For collection of BAL cells, mice were killed and the lungs
flushed three times with 1 ml of PBS through a bluntedPage 2 of 11
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treated with Tris-NH4Cl (0.14 M NH4Cl in 17 mM Tris,
adjusted to pH 7.2) to lyse erythrocytes, washed in RPMI
1640 medium supplemented with 10% FCS and cell via-
bility was determined via trypan blue exclusion. For dif-
ferential counts, aliquots of approximately 5 × 104 BAL
cells were cyto-centrifuged onto glass microscope slides,
dried and stained with Diff Quick (Lab Aids, Australia).
Slides were examined using a light microscope and a min-
imum of 100 cells in 4-8 random fields was counted
(×1000 magnification). Macrophages, lymphocytes and
neutrophils were identified by their distinct nuclear mor-
phologies.
Sera, mAbs and SP-D
Mouse serum was collected from blood that had clotted at
4°C overnight followed by storage at -70°C. Recom-
binant rat SP-D was a gift from Prof. Erika C. Crouch,
Department of Pathology, Washington University School
of Medicine, St. Louis, Missouri, USA. The anti-HA mAbs
CY3/3, PA1/1 and C1/1 raised against BJx109 (A/Beijing/
353/89 × A/PR/8/34) were prepared by Dr. Georgia Kapa-
kalis-Deliyannis, Department of Microbiology and
Immunology, University of Melbourne. mAb D7/1, raised
against A/Philippines/2/82 (Phil/82), was prepared by
Dr. E. M. Anders, Department of Microbiology and Immu-
nology, University of Melbourne.
Virus Neutralization assays
Neutralization of virus infectivity was measured by fluo-
rescent-focus reduction in monolayers of MDCK cells cul-
tured in 96-well plates (Nunc, Golstrup, Denmark) as
described [8]. Briefly, dilutions of mouse sera or recom-
binant rat SP-D were mixed with a constant dilution of
virus, and after incubation for 30 mins at 37°C, added to
MDCK cell monolayers. After adsorption of virus for 45
min at 37°C, the inoculum was removed and cells were
incubated a further 7-8 hrs to allow for infection of MDCK
cells. Cell monolayers were then fixed in 80% acetone and
stained for fluorescent foci by incubation with mAb A-3,
specific for the nucleoprotein (NP) of type A influenza
viruses, followed by fluorescein-conjugated rabbit anti-
mouse immunoglobulins (Silenus, Melbourne, Aus-
tralia).
Hemagglutination and Hemagglutination Inhibition (HI) 
assays
Hemagglutination titrations and HI tests were performed
by standard procedures using 1% (vol/vol) chicken eryth-
rocytes in Tris-buffered saline (TBS; 0.05 M Tris-HCl, 0.15
M NaCl, pH 7.2) containing 0.1% NaN3 (TBSN3).
Sequencing of HA gene
Influenza virus RNA was extracted directly from allantoic
fluid. Virus was digested with proteinase K and 0.5%
sodium dodecylsulfate (SDS) and heated to 55°C for 5
min. RNA was extracted using hot phenol, followed by
phenol-chloroform extraction and ethanol precipitation.
Full length HA cDNA was prepared from viral RNA using
AMV reverse transcriptase (Promega, U.S.A.). Two seg-
ments were then amplified from the HA gene PCR for
direct sequencing. Sequences were determined using a
PRISM Ready Reaction Dyedeoxy terminator cycle
sequencing kit (Perkin Elmer, Applied Biosystems Divi-
sion, Foster City, CA, USA). The complete sequence of HA
for the L phenotype virus has been deposited in GeneBank
(U97740).
SDS-PAGE and immunoblot for HA
Proteins from purified preparations of influenza virus
were resolved by SDS-PAGE (5-12.5% gradient gels)
under non-reducing conditions, transferred to nitrocellu-
lose and probed with 1/500 dilution of ascitic fluid of
mAbCY3/3 in TBS containing 2.5 mg/ml BSA. After wash-
ing, bound antibody was detected with 1/400 dilution of
HRP-conjugated rabbit anti-mouse immunoglobulins
(Dako, Glostrup, Denmark). SeeBlue pre-stained stand-
ards (Novex, San Diego, California) were used to estimate
molecular weights.
Results
Small plaque mutants of Beij/89 emerge following 
intranasal infection of mice
In previous studies, we have used viruses of the H3 sub-
type (1968-1992) to examine the relationship between
the degree of glycosylation of the HA glycoprotein, the
sensitivity to the antiviral activities of collectins and the
ability of a particular virus strain to grow in mouse lung
[8]. Strains isolated post-1980 were found to bear high
levels of glycosylation on the HA, were highly sensitive to
neutralization by SP-D and MBL in vitro and replicated
poorly in the lungs of mice following intranasal inocula-
tion. In these studies we were surprised to find that inoc-
ulation of mice with one virus strain, Beij/89, lead to
sporadic growth of virus in mouse lung and that the
plaques derived from the lung homogenates were notice-
ably different to those observed when plaquing the virus
inoculum.
On closer inspection, we observed a small proportion
(less than 5% of >300 plaques counted) of small plaque
variants present in the original seed stock; therefore we
picked 5 large (clones L1-5) and five small (clones S1-5)
plaques, repeated the plaque purification and propagated
each clone individually in hens' eggs. Mice were inocu-
lated with the seed stock of Beij/89 and 3 days later the
phenotype of virus present in lung homogenates was
examined following plaque assay on MDCK cells. Five
plaques (all of small plaque phenotype) were picked and
propagated individually in hens' eggs (clones Mo1-5). AllPage 3 of 11
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either S or Mo plaques (1300 +/- 100 μm for L virus com-
pared to 326 +/- 17 μm and 325 +/- 19 μm for S and Mo
viruses, respectively. n = > 10 plaques measured for each
sample). Together, these findings suggest that a mouse vir-
ulent variant of Beij/89 was present at low frequency in
the seed stock of Beij/89 and that this variant is rapidly
selected to become dominant following intranasal infec-
tion of mice.
Enhanced replication of small plaque mutants of Beij/89 in 
the respiratory tract of mice
Plaque purified clones of L, S and Mo viruses were com-
pared for their ability to replicate in mouse lung (Fig. 1A).
Mice were inoculated with 105 PFU of the uncloned stock
of Beij/89 or with an equivalent dose of L, S and Mo
viruses and, 3 days later, mice were killed and titres of
infectious virus in lung homogenates were determined
using a standard plaque assay. Variable virus titres were
recorded in the lungs of mice infected with uncloned Beij/
89 while virus titres were very low or undetectable in lung
homogenates from mice infected with L plaque virus. Of
interest, virus titres were 10-100 fold higher in the lungs
of mice infected with either S or Mo viruses.
We next examined the time course of viral replication
using 1 representative clone of each of the L, S and Mo
Beij/89 viruses. Compared to L virus, S and Mo viruses
replicated to higher titres in both the lungs (Fig. 1B) and
the nasal tissues (Fig. 1C) of infected animals at all time-
points examined. Virus could not be detected in the lungs
of mice infected with the L phenotype virus after day 3
post-infection but was recovered from most animals
infected with S or Mo viruses up to 7 days after infection
(8/10 animals infected with S virus, 7/10 animals infected
with Mo virus at day 7 post-infection), indicating a
marked delay in clearance from the lungs. A similar trend
was observed in the upper respiratory tract with delayed
clearance of S and M viruses compared to L virus-infected
mice (Fig. 1C).
Airway inflammation is exacerbated in mice infected with 
small plaque mutants of Beij/89
To assess the acute inflammatory response to infection,
mice infected with L, S or Mo viruses were killed at 3 and
7 days post-infection, and the cells recruited to the air-
spaces of the lung were recovered and characterized by dif-
ferential staining. Macrophages were the predominate cell
type recovered in the BAL at day 3 and 7 post-infection
(Fig. 2A), and numbers were significantly higher in the
lungs of mice infected with S or Mo viruses at day 7 post-
infection compared to mice infected with L virus. Few
neutrophils were present in the BAL of naive mice (N; <
1% of all BAL cells) but rose markedly at day 3 post-infec-
tion and declined thereafter (Fig. 2B), consistent with
Small plaque variants of Beij/89 show enhanced virulence for miceFigure 1
Small plaque variants of Beij/89 show enhanced viru-
lence for mice. (A) Replication of uncloned Beij/89 (Un) 
and plaque purified L, S or Mo viruses in mouse lung. Data 
shown represent virus titres in the lungs of 5 mice inoculated 
3 days prior with 105 PFU of virus. Data was confirmed with 
5 independent clones of L, S and Mo viruses. (B & C) Time 
course of virus titres recovered from the respiratory tract of 
mice following intranasal inoculation with 105 PFU of L, S or 
Mo viruses. Infectious virus present in (B) lung or (C) nasal 
tissues was determined at various times post-infection by 
plaque assay on MDCK cell monolayers. Virus titres are 
shown as the mean ± 1 SD of 5 mice. The dashed line repre-
sents the lower limit of detection of virus in each sample 
(2.1) and for statistical analysis samples with a value below 
the limit of detection were assigned an arbitrary value of 2.0. 
* = p < 0.01, Kruskal-Wallis test.Page 4 of 11
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Mice infected with S or Mo viruses had significantly higher
neutrophil BAL counts compared to L virus-infected mice
at both day 3 and 7 post-infection. At day 7, a significant
influx of lymphocytes was observed in BAL of mice
infected with S and Mo viruses (Fig. 2C), that was not
observed in the airways of L virus-infected animals.
Together, these data indicate that infection of mice with S
or Mo viruses leads to enhanced recruitment of inflamma-
tory cells to the lungs during the early (day 3) and latter
(day 7) phases of infection.
Small plaque mutants of Beij/89 are less sensitive to 
neutralization by murine collectins
Collectins function as β inhibitors against influenza
viruses, binding in a Ca2+-dependent manner to man-
nose-rich glycans at the tip of the HA spike resulting in
steric hindrance of binding of the viral HA to host cell
receptors [1,13]. Early studies demonstrated that H1 sub-
type viruses that had undergone adaptation resulting in
increased growth in mice had also developed resistance to
HI by β inhibitors [14,15], consistent with an important
role for collectins in innate host defence. Therefore, we
tested S, L and Mo viruses for their sensitivity to hemag-
glutination inhibition by rat SP-D or by MBL in mouse
serum. Both SP-D and MBL were able to mediate HI activ-
ity against L, S and Mo viruses, and activity was Ca2+-
dependent and blocked by the sugar mannose (data not
shown). Viruses did, however, differ in their sensitivity to
both SP-D (Fig. 3A) and MBL (Fig. 3B) in a neutralization
assay. L viruses were markedly more sensitive to neutrali-
zation by either murine collectin when compared to S and
Mo viruses. The neutralizing activity of SP-D or MBL
against L, S or Mo viruses was abrogated in the presence of
50 mM D-mannose (data not shown).
Loss of an N-linked glycan from the HA of small plaque 
variants of Beij/89
MBL in mouse serum and rat SP-D bind to the HA and NA
glycoproteins of influenza virus, with the majority of
binding to the HA molecule [8]. Given the reduced sensi-
tivity of S and Mo viruses to neutralization by murine col-
lectins, we compared viruses for their reactivity to a panel
of HA-specific mAbs to determine if any antigenic changes
could be detected in HA (Figure 4A). L, S and Mo viruses
reacted equally well with mAbs PA1/1, CY3/3 and C1/1
however S and Mo viruses showed a 30-fold higher HI
titre that did L viruses against mAb D7/1. The enhanced
reactivity of mAb D7/1 with S and Mo viruses suggests
that amino acid changes common to the small plaque
mutants of Beij/89 affect the antigenic epitopes recog-
nized by this mAb.
To determine if the reduced sensitivity of S and Mo viruses
to neutralization by murine collectins was associated with
loss of a glycosylation site from the HA molecule, proteins
Increased recruitment of inflammatory cells to the airways of mic  infect d wi h small plaque v riants of Beij/89Figure 2
Increased recruitment of inflammatory cells to the 
airways of mice infected with small plaque variants of 
Beij/89. Mice were infected with 105 PFU of L, S or Mo 
viruses and, at day 3 or day 7 post-infection, mice were killed 
and BAL performed. BAL cells were centrifuged onto glass 
slides, stained with Diff Quick and the number of macro-
phages, neutrophils and lymphocytes were determined by 
nuclear morphology. Cell numbers from BAL of naïve (N) 
mice are included for comparison. Data represent the mean 
(± 1 SD) number of (A) macrophages, (B) neutrophils or (C) 
lymphocytes from groups of 5 mice and are representative of 
2 independent experiments. * = p < 0.01, Kruskal-Wallis test.Page 5 of 11
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PAGE under non-reducing conditions and the HA glyco-
protein was detected by western blot using mAb CY3/3.
Under these conditions, the HA runs as a series of bands
corresponding to monomers, dimmers, trimers and
higher molecular weight forms of the 80 kDa molecule
(Fig. 4B). Loss of a glycan from HA should result in a
reduction in molecular weight and therefore increased
mobility of the HA on SDS PAGE. Consistent with this,
the HA of both S and Mo viruses had increased electro-
phoretic mobility compared to that of the L virus (Fig.
4B).
To confirm loss of a glycosylation site from the HA of S
and Mo viruses and to determine the location of this site,
the cDNA of 3-5 isolates of L, S and Mo viruses was
obtained by reverse transcription of viral genomic RNA
and the complete HA1 and HA2 gene segments of each
virus were amplified by PCR and sequenced. The amino
acid sequence of the HA1 of L phenotype viruses was iden-
tical to that of A/Beijing/353/89 as determined by [16]
(GeneBank L76036). The entire HA1 and HA2 sequences
of S and Mo viruses were identical and differed from L
viruses by a single base substitution (A814→T) in HA1, giv-
ing rise to amino acid substitution Asn to Ser at residue
246. This substitution deletes the potential glycosylation
site Asn246-Ser247-Thr248 on the HA1 of the S and Mo
viruses. No differences were noted in the sequence of NA
or M2 proteins between clones of L, S and Mo viruses.
L, S and Mo viruses do not differ in their ability to infect or 
replicate in murine respiratory epithelial cells
The enhanced ability of S and Mo viruses to grow in
mouse lung could relate to their ability to avoid a compo-
nent of host defence, but could also reflect an inherent
increased efficiency in the ability of these viruses to infect
or replicate in epithelial cells lining the respiratory tract.
As the balance of HA and NA activity of a virus can affect
the efficiency of cell entry [17], we first compared the abil-
ity of viruses to bind and elute from LA-4 cells, a mouse
respiratory epithelial cell line (Fig. 5A). In this assay, each
virus was incubated, in duplicate, with fixed LA-4 cells on
ice to allow virus adsorption, and then one tube was
shifted to 37°C for 30 min to allow NA activity to elute
virus from the cell surface. After centrifugation of samples,
the virus present in the supernatant was quantified by
hemagglutination assay. Each virus strain bound effi-
ciently to LA-4 cells on ice (as indicated by reduced
hemagglutinating activity), and all eluted to a similar
degree when moved to 37°C (as indicated by an increase
in hemagglutinating activity).
Next, we determined the susceptibility of LA-4 cells to
infection by L, S and Mo viruses. In this assay, cell monol-
ayers were incubated with increasing concentrations of L,
Neutralization of plaque purified L, S and Mo clones of Beij/89 by the mann se-binding lectin in normal mouse serum and recomb n nt rat SP-DFig e 3
Neutralization of plaque purified L, S and Mo clones 
of Beij/89 by the mannose-binding lectin in normal 
mouse serum and recombinant rat SP-D. L, S and Mo 
viruses were incubated with dilutions of (A) mouse serum or 
(B) rat SP-D for 30 mins at 37°C, and the amount of infec-
tious virus remaining was determined by fluorescent focus 
assay. The total number of fluorescent foci in four represent-
ative fields were counted and expressed as a percentage of 
the number of foci in the corresponding area of duplicate 
control wells infected with virus alone ('Percent of virus con-
trol'). The neutralizing activity of 1/100 dilution of mouse 
serum or 1 μg/ml rat SP-D was inhibited by addition of 100 
mM mannose to serum or SP-D prior to addition of virus 
(data not shown) demonstrating that the major neutralizing 
activity in each sample was a mannose-specific lectin.Page 6 of 11
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post-infection to detect newly synthesized nucleoprotein
(NP) in virus-infected cells. As seen in Fig. 5B, no signifi-
cant differences were detected in the ability of viruses to
infect murine respiratory epithelial cells in vitro, regardless
of the inoculum dose used. An additional factor that
could modulate viral load in the airways is the capacity of
L, S and Mo viruses to replicate and release newly synthe-
sized virions from airway epithelial cells. Therefore, mon-
olayers of LA-4 cells were infected with 10 PFU/cell of L, S
and Mo viruses, washed extensively to remove unbound
virus and incubated 2 or 24 hrs before titres of infectious
virus in cell-free supernatant were determined by plaque
assay. As seen in Fig. 5C, viral titres increased markedly
between 2 and 24 hrs, indicative of productive virus repli-
cation, however no significant differences were noted in
ability of L, S and Mo viruses to replicate in these cells.
Clearance of L virus, but not S or Mo viruses, from mice by 
the innate immune system
C-type lectins, including MBL and SP-D, play an impor-
tant role in innate host defence and we have shown that S
and Mo viruses are markedly more resistant to neutraliza-
tion by rat SP-D and murine MBL (Fig. 3). Furthermore,
B6 mice infected with L virus had cleared virus from the
lung by day 5 post-infection (Fig. 1B), suggesting that
infection was effectively controlled and eliminated by the
innate immune system. To test this further, B6.RAG-/- mice
that lack T and B cells were infected with 105 PFU of L, S
and M viruses and monitored daily for weight loss and
signs of clinical disease. B6.RAG-/- mice infected with L
virus did not lose weight (Fig. 6A) did not show any signs
of clinical disease (data not shown) and all mice survived
infection (Fig. 6B). In contrast, mice infected with S or M
viruses lost weight progressively, developed clinical dis-
ease (rapid breathing, huddling behaviour, lethargy) and
all mice succumbed to infection within 8-14 days.
Discussion
Members of the collectin family can function as β inhibi-
tors of influenza virus and have been implicated in play-
ing an important role in innate host defence during
influenza infections. For H3 subtype influenza viruses,
sensitivity to β inhibitors has been shown to correlate
with the presence of a mannose-rich oligosaccharide at
residue 165, located at the tip of the HA spike. In this
study we have identified a second glycosylation site at res-
idue 246 on the globular head of H3 subtype viruses that
Loss of a N-linked glycosylation site from the HA of S and Mo clones of Beij/89Figure 4
Loss of a N-linked glycosylation site from the HA of S and Mo clones of Beij/89. (A) HI titres of anti-HA monoclon-
cal antibodies against L, S and Mo clones of Beij/89. HI titres are expressed as the recipricol of the highest dilution of ascites 
fluid to inhibit 4 hemagglutinating units (HAU) of virus. Data presented are the mean of 3 independent experiments and are 
representative of results obtained with 3-5 independent clones of L, S or Mo viruses. * = p < 0.01, Kruskal-Wallis test. (B) 
Immunoblot showing the HA proteins of plaque-purified L, S and Mo clones of Beij/89. Proteins from purified viruses were 
resolved by SDS-PAGE under non-reducing conditions on a 5-10% gel and transferred to a nictrocellulose membrane. To 
detect the HA glycoproteins, the blot was incubated with anti-HA mAb CY3/3 and developed, as described in Materials and 
Methods. The location of the HAO monomer at approximately 80 kDa is indicated with an arrow.Page 7 of 11
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for mice. Loss of glycosylation site 246 was not associated
with classical resistance to β inhibitors when assessed by
HI assay, however mutant viruses lacking this site were
shown to be more resistant to neutralization by murine
MBL and SP-D in vitro. Mutant viruses showed no differ-
ence in their ability to replicate in respiratory epithelial
cells in vitro, but were markedly more virulent following
intranasal inoculation of mice. These studies provide fur-
ther evidence that multiple glycosylation sites on the HA
of H3 subtype influenza viruses are involved in determin-
ing sensitivity to the antiviral activities of collectins both
in vitro and in vivo.
In previous studies we have reported a strong correlation
between the degree of glycosylation of the influenza virus
HA, sensitivity of particular virus strains to neutralization
by collectins and their virulence in mice [8]. Virus strains
of the H3 subtype isolated after 1982 were particularly
sensitive to neutralization by murine SP-D and MBL in
vitro and were very poor in their ability to replicate in
mouse lung. Compared to earlier virus strains, Phil/82,
Beij/89 and Beij/92 had acquired an additional glycosyla-
tion site at residue 246 of HA1 and this site appeared to be
associated with the enhanced sensitivity of these viruses to
neutralization by collectins. Virus mutants selected for
resistance to β inhibitors lack oligosaccharide attachments
at residue 165 (H3 subtype) or 104 (H1 subtype)[1,13],
yet recent evidence suggests additional glycans on the viral
HA also contribute to SP-D-mediated antiviral activity.
The use of reverse genetics to engineer additional sites of
glycosylation into the globular head of the HA of A/Hong
Kong/1/68 (H3N2) resulted in viruses that were more
sensitive to inhibition by human SP-D and showed atten-
uated disease in mice [18]. Sequential addition of glyco-
sylation to sites 63, 126 and 246 was associated with step-
wise increases in sensitivity to SP-D. Glycosylation site
165 has been shown to carry high-mannose glycans in
early H3 virus strains such as A/Aichi/2/68 and Memphis/
102/72 [19,20], however Beij89 (L virus) carries addi-
tional sites of potential N-linked glycosylation at residues
63, 126, and 246 on the head of HA and, if glycosylated,
the nature of specific glycans remains to be defined. The
enhanced resistance to SP-D associated with loss of glycan
246 from Beij/89 is consistent with the expression of man-
nose-rich oligosaccharides at this site although the sugar
specificity of SP-D does not exclude interactions with
complex or hybrid-type glycans. Of interest, recent studies
comparing H3N2 virus strains implicated additional gly-
can attachments at positions 122, 133 and 144 in contrib-
uting to the enhanced sensitivity of post-1995 H3N2
subtype viruses to human SP-D [21].
Inhibition of the hemagglutinating activity of influenza
viruses represents a simple and convenient assay for deter-
Beij/89 viruses do not differ in their ability to bind to, infect or replicate in murine respiratory epithelial cellsFigure 5
Beij/89 viruses do not differ in their ability to bind to, 
infect or replicate in murine respiratory epithelial 
cells. (A) Ability of viruses to bind to and elute from the epi-
thelial cell surface. Duplicate tubes of formaldehyde-fixed 
LA-4 epithelial cells were mixed with 100 HAU of L (white 
columns), S (black columns) or Mo (striped columns) viruses 
for 1 hr on ice. After virus adsorption, one sample was held 
at 4°C ('4°C') while the duplicate tube was transferred to 
37°C for 30 min ('37°C'). A third tube with no cells received 
virus alone ('control') and was held on ice throughout. Fol-
lowing centrifugation of samples, virus in each of the super-
natants was quantified by hemagglutination assay. Data 
shown are the mean ± 1 SD HAU from 3 independent 
experiments. (B) Monolayers of LA-4 cells were infected in 
chamberslides with increasing doses of L, S and Mo viruses as 
described in Materials and Methods. At 6-8 hrs post-infection 
cells were fixed and stained via immunofluorescence for 
expression of influenza virus NP. Data represents the mean 
percent infection ± 1 SD from 4-8 independent fields per 
chamber. (C) Release of infectious virus from influenza virus-
infected LA-4 cells. Monolayers of cells were infected with L, 
S or Mo viruses at a multiplicity of infection of 10 PFU/cell 
and, after 1 hr, washed to remove any unbound virus. Sam-
ples of supernatant were removed at 2 hrs and 24 hrs and 
levels of infectious virus determined by plaque assay on 
MDCK cells. The fold increase in infectious virus was calcu-
lated by dividing the viral titre obtained at 24 hrs post-infec-
tion by that at 2 hrs. Data are the mean ± 1 SD from 3 
independent experiments.Page 8 of 11
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of the inhibitor to block access of viral HA to sialylated
erythrocyte receptors. For H3 subtype viruses, the pres-
ence of a mannose-containing oligosaccharide at residue
165 has been shown to be critical for determining sensi-
tivity to HI by β inhibitors in bovine and mouse serum
[1], as well as by purified SP-D [22]. The current study
indicates that additional glycosylation sites on HA, such
as that at residue 246 on the HA of Beij/89, also play an
important role in other antiviral activities mediated by
collectins, such as neutralization of virus infectivity. Due
to the multimeric nature of collectins, additional glyco-
sylation sites on the head of HA presumably facilitates an
enhanced degree of binding, thereby strengthening the
overall affinity with which a collectin can bind to and
inactivate virus. Previously, a mutant H3N2 virus selected
for resistance to rabbit serum was found to have lost a
potential glycosylation site at residue 246 on HA1 [23]
and subsequent studies demonstrated that the inhibitor
in rabbit sera was a mannose-binding lectin [24]. Our
study has extended these findings to demonstrate the crit-
ical role of this glycosylation site in determining sensitiv-
ity to murine SP-D, which is found in airway secretions,
and in modulating virulence in a mouse model of influ-
enza infection.
The presence of the small plaque mutant in the seed stock
of Beij/89 suggests that loss of the glycosylation site at res-
idue 246 on the HA1 of Beij/89 confers a growth advan-
tage upon cultivation of virus in eggs. Egg adaptation has
been associated with a number of sequence changes that
alter potential N-linked glycosylation sites on the HA,
including the site at residue 246 of H3 subtype viruses
[25-27] although loss of this site from particular H3 field
strains was not associated with adaptation to growth in
eggs [16]. In general terms, amino acid substitutions asso-
ciated with egg-adapted variants cluster around the recep-
tor-binding site on the HA molecule [28] and are likely to
increase binding to Sia(α2,3)Gal moieties on cells of the
chicken embryo chorio-allantoic membrane, the site of
influenza virus replication in chicken eggs. N-linked gly-
cans in the vicinity of the receptor-binding site have been
proposed to sterically interfere with binding to
Sia(α2,3)Gal-containing macromolecules and so may be
lost during adaptation to growth in eggs [29].
In studies not presented here, L, S and Mo viruses showed
no differences in their ability to agglutinate chicken eryth-
rocytes that had been treated with increasing concentra-
tions of periodate or Vibrio cholerae neuraminidase to
oxidize or remove sialic acid residues, nor in their ability
to agglutinate erythrocytes from a variety of avian or
mammalian species (chicken, turkey, monkey, guinea pig,
mouse, rabbit, cow and human erythrocytes), and on this
basis, displayed no evidence of modified receptor specifi-
city. Subtle differences in the fine specificity of receptor
binding between the Beij/89 variants that went undetec-
ted in these assays could, however, be of particular rele-
vance during growth of viruses in eggs or in mouse lung.
It is well established that Sia(α2,3)Gal moieties are
expressed throughout the murine respiratory tract [30],
however our findings that L, S and Mo viruses are similar
in their ability to infect and replicate in murine respiratory
epithelial cells (Fig. 6) suggests that changes in S and Mo
mutant viruses has not altered the intrinsic ability of these
viruses to replicate in the appropriate target cells. Instead,
their enhanced growth in mouse lung likely represents
evasion of a particular host defence mechanism.
S and Mo variants of Beij/89 are lethal for RAG1-/- mice but L variants are notFigure 6
S and Mo variants of Beij/89 are lethal for RAG1-/- 
mice but L variants are not. Groups of 5 mice infected 
with 105 PFU of Beij/89 viruses via the intranasal route were 
examined daily for weight loss and signs of disease. (A) 
Weight loss and (B) survival curves are shown for mice inoc-
ulated with L, S or Mo viruses. Mice were weighed daily and 
results expressed as the mean percent weight change of each 
group (± SEM), compared to original body weight. Animals 
that had lost ≥20% of their original body weight and/or pre-
sented with evidence of pneumonia were euthanized.Page 9 of 11
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HA1 and alterations in this site could presumably influ-
ence other functions mediated by the viral HA. While
receptor binding by the viral HA is required for binding
and entry of virus into target cells, efficient fusion of viral
envelope with endosomal membranes in the target cell is
required to initiate infection. Previous studies implicated
residue 246 on the HA of A/Philippines/2/82 (H3N2) as
a critical residue influencing stability of HA at low pH
[13], a factor critical in inducing the conformational
change of the HA to expose the fusion peptides in the
acidic environment of the endosome [31,32]. However, L,
S and Mo viruses were found to be similar in their ability
to mediate hemolysis of human erythrocytes over a range
of pH using the fusion assay described ([33], unpublished
observations). Sequencing of the NA gene of multiple
clones of S or Mo viruses confirmed that there were no
amino acid substitutions in the NA, consistent with our
findings that its enzymatic activity was not significantly
different between L, S and Mo viruses when assessed by
ELISA [8] (unpublished observations).
Particular stains of influenza virus appear to be intrinsi-
cally more virulent than others, due largely to their ability
to cause viral pneumonia and/or predispose the host to
bacterial super-infection. Factors determining the viru-
lence of particular virus strains are not fully understood
although a number of lines of evidence suggest that in
humans, as in mice, glycosylation may modulate viral vir-
ulence. Neither the virulent 1918 Spanish influenza pan-
demic virus (H1N1) [34] nor the mouse-adapted A/PR/8/
34 (H1N1) [35] virus carry potential sites for N-linked
glycosylation on the head of HA and human H5N1 iso-
lates were resistant to HI by human SP-D [21], consistent
with the notion that virulent strains carry less glycosyla-
tion to evade collectin-mediated defences. Following its
appearance in the human population, the H3N2 strain of
1968 contained only 2 sites on the globular head of HA,
and despite the presence of oligomannose at residue 165
[20], early H3 strains were partially resistant to SP-D
[8,21]. In the process of antigenic drift, the accumulation
of glycosylation on the head of HA may shield the virus
from pre-existing antibody in the human population
[12,36] but increase sensitivity to collectin-mediated anti-
viral activities. While evidence indicates the maintenance
of extensive glycosylation on the head of recent H3 viruses
[37,38], loss of glycosylation from the HA of particular
human isolates [16,39,40] argues for the existence of a
fine balance between protection afforded by antibody and
increased sensitivity to SP-D.
Conclusion
Members of the collectin family function as β inhibitors of
influenza virus and play an important role in innate
defence during influenza infections. For H3 subtype
viruses, the mannose-rich oligosaccharide at residue 165,
located at the tip of the HA molecule, is a critical factor in
determining sensitivity to β inhibitors. In this study, we
identify a second glycosylation site on the head of the HA
of virus strain Beij/89 (H3N2) that enhances sensitivity to
collectins and attenuates virulence for mice. While it is
well established that accumulation of glycosylation on the
head of HA may shield the virus from pre-existing anti-
body in the human population, our findings provide evi-
dence that glycosylation at specific sites will increase
collectin binding to the viral HA. As a virus persists in the
human population, a balance between protection from
antibody-mediated neutralization and sensitivity to par-
ticular innate host defences is likely to determine the most
favourable glycosylation pattern of a particular virus
strain.
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